MO-St. Louis, Kforce has an exciting Senior R&D Synthetic Chemist opening at a local pharmaceutical company! The incumbent will be responsible for producing new pharmaceutical API's for bulk and dosage use. This pe[...]
Interesting article in today’s Wall Street Journal on the use of genetic tools to resuscitate failed compounds. Here how the story begins: “As pharmaceutical makers find it increasingly difficult to bring new drugs to market, they are turning to genetic tools to seek uses for medicines that failed to make [...]
File this under creative marketing. A union that represents about 50,000 emergency medical technicians and paramedics recently mailed a letter to its "approved physician network" endorsing the use of Pfizer's Lipitor cholesterol pill. The letter isn't dated, but does a carry a Pfizer trademark for 2007. "When appropriate, we ask [...]
That would be Frederick Schiff, who is scheduled to go on trial today on two felony counts of conspiracy and securites fraud for his role in an alleged channel stuffing scheme to inflate the drugmaker's earnings between 2000 and 2002. Last week, US District Court Judge Faith Hochberg greatly narrowed [...]
Britain plans to force pharmaceutical companies to share more information with regulators about clinical trials after an investigation recently concluded that GlaxoSmithKline PLC deliberately withheld information about an antidepressant. Read More Permalink[...]
ChinaBio Today submits: Tongjitang Chinese Medicines Company (TCM) will pay 25.5 million RMB ($3.5 million) to buy Qinghai Pulante Pharmaceutical Co. Ltd.Complete Story »[...]
Cambrex Corp. announced that one of its customers is recalling a product for which Cambrex currently supplies the active pharmaceutical ingredient (API). The recall decision is not linked to Cambrex's performance as the manufacturer of the API. The recall may impact Cambrex's 2008 performance. Until the customer has resolved the [...]
